Scribd
Upload
19 views4 pages

Assignment 1

The document discusses the critical role of nurses in medication management, emphasizing the importance of verifying prescriptions and understanding legal requirements for safe administration. It identifies human factors contributing to medication errors and suggests strategies for risk reduction, such as double-checking and ongoing training. Additionally, it covers specific procedures for administering insulin and monitoring IV medications, highlighting the need for careful calculation and observation of patient responses.

Uploaded by

leo tanhamira
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
19 views4 pages

Assignment 1

The document discusses the critical role of nurses in medication management, emphasizing the importance of verifying prescriptions and understanding legal requirements for safe administration. It identifies human factors contributing to medication errors and suggests strategies for risk reduction, such as double-checking and ongoing training. Additionally, it covers specific procedures for administering insulin and monitoring IV medications, highlighting the need for careful calculation and observation of patient responses.

Uploaded by

leo tanhamira
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 4

Q1: Critical discussion of future registrants' role in identifying legal requirements of

medication prescription

Nurses play a pivotal role in the management of medicines in relation to patient safety, service
efficiency and cost management. Before a patient is administered any form of medicinal
product it is the role of the nurse to ensure that there is a legit prescription from a valid
healthcare professional and the drug to be administered adheres to the MHRA standards. The
MHRA approves use of drugs by stating the indications of disease or illness, the age of patient it
should be applied to, the dosage according to weight and the route of administration. It is
required that registrants understanding their scope of practice, ensuring prescriptions are
appropriate, safe, and necessary, and maintaining relevant knowledge and practice updates.
They must also be aware of local policies and procedures, and understand the legal and ethical
implications of their prescribing decisions.

In the scenario provided, appendix 2 gives the Patient Specific Direction which outlines

As a future registrant, it's essential to understand the legal requirements of medication


prescriptions to ensure safe and effective medication administration. The Nursing and
Midwifery Council (NMC) guidelines emphasize the importance of verifying the prescription's
accuracy and completeness before administering medication (NMC, 2018). Key legal
requirements include the patient's name and address, date of prescription, medication name,
dose, and frequency, route of administration, doctor’s signature and registration and signature
of prescriber (Royal Pharmaceutical Society, 2019).

Q2a: Human factors contributing to medication errors and strategies to reduce risk

Human factors contributing to medication errors include fatigue and workload, lack of attention
to detail, poor communication, and inadequate training (Reason, 2000). Strategies to reduce
risk include double-checking medications with a colleague, using barcode scanning technology,
implementing standardized medication administration procedures, and providing ongoing
education and training for healthcare professionals (Leape et al., 1995). From the PSD/MAR
chart shown in appendix 1 the main source of e
Q2b: Identifying medication errors on the PSD/MAR chart

When analyzing the PSD/MAR chart shown on appendix 1 there are errors thT , potential errors
may include incorrect dosing or frequency, omission of medications, or incorrect medication
administration. Actions to be taken include notifying the prescriber and clarifying the order,
correcting the error and documenting the correction, and reviewing the patient's medication
regimen to prevent future errors (NMC, 2018). The main errors shown on the on appendix 1 on
the scenario are that the prescriber didn’t indicate the frequency of the drug administration wh

Q3: Administering Insulin NovoRapid

When preparing Insulin NovoRapid, it's essential to verify the patient's identity and the
prescription, check the expiration date and label of the insulin vial, use aseptic technique when
drawing up the insulin, and administer the insulin via the prescribed route (subcutaneously)
(Diabetes UK, 2020). Risk management strategies include monitoring blood glucose levels,
adjusting insulin doses according to the patient's needs, and educating the patient on self-
administration techniques (Inzucchi et al., 2015).

Q4a: Calculating flow rate for IV fluids

To calculate the flow rate, we need to know the total volume of fluid and the duration of
infusion. Formula: Flow rate (mL/h) = Total volume (mL) / Duration (hours) ( Dougherty & Lister,
2015).

Q4b: Monitoring considerations for IV medications

Administration of a drug through intravenous involve applying the medication of interest into
the bloodstream via the venous system. This system is effective because the medication quickly
becomes effective in around 10-20 minutes. In scenario under study due to the high When
administering medications via the IV route, monitoring considerations include vital signs (e.g.,
blood pressure, heart rate), electrolyte levels (e.g., potassium), fluid balance, and signs of
adverse reactions or toxicity (Royal College of Nursing, 2016). According to Diabetes UK,
glycated haemoglobin (HbA1c) is glucose that is stuck in the blood that cannot be used
properly. The reference range of HbA1c in nondiabetetic In the UK, this range is typically
aligned with the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC),
which allows for global comparison of results. For individuals with diabetes, an ideal HbA1c
level is generally 48 mmol/mol (6.5%) or lower.

Reference List:

Diabetes UK. (2020). Insulin therapy. Retrieved from (link unavailable)

Dougherty, L., & Lister, S. (2015). The Royal Marsden Hospital manual of clinical nursing procedures.
Wiley Blackwell.

Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., ... & Matthews, D. R.
(2015). Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Diabetes
Care, 38(1), 140-149.

Leape, L. L., Bates, D. W., Cullen, D. J., Cooper, J., Demonaco, H. J., Gallivan, T., ... & Vander Vliet, M.
(1995). Systems analysis of adverse drug events. JAMA, 274(1), 35-43.

General Medical Council (2021) Good practice in proposing, prescribing, providing and managing
medicines and devices,

Nursing and Midwifery Council. (2018). Standards for medicines management. Retrieved from (link
unavailable)

Reason, J. (2000). Human error: models and management. BMJ, 320(7237), 768-770.

Royal College of Nursing. (2016). Standards for infusion therapy. Retrieved from (link unavailable)

Royal Pharmaceutical Society. (2019). Professional standards for hospital pharmacy services. Retrieved
from (link unavailable)
Nursing and Midwifery Council (2010) Standards of proficiency for nurse and midwife prescribers, r

Registrants should keep up-to-date with relevant guidance, including the British National Formulary
(BNF), NICE guidelines, and other relevant professional guidance.

NovoRapid® contains the active ingredient insulin aspart. Insulin aspart is a rapid-acting insulin used to
treat diabetes mellitus in adults and children. Novorapid has adverse effects when administered to a
patient to NovoRapid. NovoRapid® lowers your blood sugar level after injection. When injected under
your skin, NovoRapid® has a faster onset of action than soluble human insulin. It takes effect within 10
to 20 minutes. Usually, the maximum effect will occur between 1-3 hours after injection and the effect
may last for up to 5 hours.

Basal insulins - basal insulins provide a steady amount of background insulin activity over the course of a
day

In the UK, this range is typically aligned with the International Federation of Clinical Chemistry and
Laboratory Medicine (IFCC), which allows for global comparison of results. For individuals with diabetes,
an ideal HbA1c level is generally 48 mmol/mol (6.5%) or lower.

You might also like